[Acute myelogenous leukemia with multilineage myelodysplasia, positive direct Coombs test, and elevated levels of platelet-associated IgG]

Rinsho Ketsueki. 2007 May;48(5):407-11.
[Article in Japanese]

Abstract

A 75-year-old man was admitted to our hospital in October, 2005 for examination of pre-diagnosed pancytopenia. His bone marrow showed myeloid dysplasia, and 30.4% of the nucleated cells were blasts. Our diagnosis was acute myelogenous leukemia with multilineage myelodysplasia (AML with MLD; WHO classification). A direct Coombs test proved positive, and the platelet-associated IgG (PA-IgG) level was elevated. After treatment with CAG (Ara-C + ACR + G-CSF), complete remission was obtained, showing negative on the direct Coombs test with PA-IgG levels returned to normal. The patient subsequently relapsed, testing positive on the direct Coombs test and experiencing a re-elevation of PA-IgG levels. We report here a first case of AML with MLD, direct Coombs test and PA-IgG assay.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aclarubicin / administration & dosage
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Blood Platelets / immunology*
  • Coombs Test*
  • Cytarabine / administration & dosage
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Humans
  • Immunoglobulin G / blood*
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / drug therapy
  • Male
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / complications*
  • Myelodysplastic Syndromes / diagnosis*
  • Myelodysplastic Syndromes / drug therapy
  • Pancytopenia / etiology
  • Prednisolone / administration & dosage
  • Treatment Outcome

Substances

  • Immunoglobulin G
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Aclarubicin
  • Prednisolone

Supplementary concepts

  • CAG protocol